Deep brain stimulation
DeviceDeep Brain Stimulation in patients with Parkinson Disease, Dystonia and Essential Tremor.
NCT Number: NCT03664609
The primary objective of this study is to characterize real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.
Interested in participating?
Request InfoAll sexes
Observational
AZ St. Lucas, Ghent, Belgium
The purpose of this study is to characterize
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Deep Brain Stimulation in patients with Parkinson Disease, Dystonia and Essential Tremor.
Time frame: 5 yrs. post implant
Improvement in disease symptoms as assessed by Unified Parkinson's Disease Rating Scale (UPDRS III) at up to 5 years post implant compared to baseline
Contact information is provided by the study sponsor or research team.
Cleo Mertz
CONTACT
Diane Keesey
CONTACT
Boston Scientific Corporation
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06553625
Basal Ganglia Diseases, Brain Diseases
Cologne, Germany
View Trial DetailsNCT04286308
Basal Ganglia Diseases, Brain Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT04071847
Basal Ganglia Diseases, Brain Diseases
Tucson, Arizona, United States
View Trial DetailsNCT05317390
Basal Ganglia Diseases, Brain Diseases
Boston, Massachusetts, United States
View Trial Details